{
    "2020-09-10": [
        [
            {
                "time": "2020-10-05",
                "original_text": "Breakout Industries With Huge Potential For Massive Gains",
                "features": {
                    "keywords": [
                        "breakout",
                        "industries",
                        "potential",
                        "gains"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-06",
                "original_text": "NIH launches two trials to test blood thinners in COVID-19 patients",
                "features": {
                    "keywords": [
                        "NIH",
                        "trials",
                        "blood thinners",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-07",
                "original_text": "Sarepta Therapeutics Stock Falls On Delay In Quest For Muscular Dystrophy Treatment",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "delay",
                        "muscular dystrophy",
                        "treatment"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Covid Report: AstraZeneca Fallout Continues To Propel Moderna, Novavax Stock",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Moderna",
                        "Novavax",
                        "fallout"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "COVID-19 vaccine doses could arrive in Canada early in 2021 -minister",
                "features": {
                    "keywords": [
                        "vaccine",
                        "Canada",
                        "early",
                        "2021"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-10",
                "original_text": "Turkey considers allowing Phase III testing of Russia's COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "Turkey",
                        "Phase III",
                        "Russia",
                        "vaccine"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "international healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-11",
                "original_text": "Regeneron’s Virus Treatment Has Probably Missed the Bus",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "virus treatment",
                        "missed",
                        "bus"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-12",
                "original_text": "Pfizer, BioNTech May Supply 200M Coronavirus Vaccine Doses in EU",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "doses",
                        "EU"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-13",
                "original_text": "FDA Delays Start of Sarepta’s Gene Therapy Trial. That Doesn’t Faze the Stock’s Bulls.",
                "features": {
                    "keywords": [
                        "FDA",
                        "delay",
                        "gene therapy",
                        "trial",
                        "Sarepta"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-14",
                "original_text": "Pausing of AstraZeneca's Coronavirus Study Aids Pfizer, Moderna",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "pause",
                        "coronavirus",
                        "study",
                        "Pfizer",
                        "Moderna"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-15",
                "original_text": "Sarepta shares fall on potential regulatory delay for experimental Duchenne drug",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "shares",
                        "fall",
                        "regulatory delay",
                        "Duchenne",
                        "drug"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-16",
                "original_text": "Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "scientific advancements",
                        "ESMO",
                        "portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-17",
                "original_text": "Pfizer's Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stealthy move",
                        "vaccine race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}